Cargando…

Dyslipidemia in Renal Transplant Recipients Treated With Cyclosporine A

Detalles Bibliográficos
Autor principal:	Niemczyk, Mariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2013
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955279/ https://www.ncbi.nlm.nih.gov/pubmed/24693512 http://dx.doi.org/10.5812/numonthly.14167

Ejemplares similares

Bioequivalence study of cyclosporine in renal transplant recipients
por: Gautam, Gagan
Publicado: (2007)

Health-Related Quality of Life in Kidney Transplant Recipients
por: Niemczyk, Mariusz
Publicado: (2013)

Monitoring of Cyclosporine A Blood Levels in Clinical Settings
por: Niemczyk, Mariusz
Publicado: (2012)

No Association Between Cyclosporine Levels and Dyslipidemia?
por: Filler, Guido
Publicado: (2014)

Dyslipidemia After Kidney Transplantation and Correlation With Cyclosporine Level: A Glimpse into the Future
por: Ahmed, Mohamed H.
Publicado: (2013)

Colchicine-induced myoneuropathy in a cyclosporine-treated renal transplant recipient
por: Huh, Kyungmin, et al.
Publicado: (2013)

Dyslipidemia After Kidney Transplantation and Correlation With Cyclosporine Level
por: Hosseini, Mahboobeh-Sadat, et al.
Publicado: (2013)

Cyclosporine Effects on Pediatric Kidney Recipients
por: Hami, Maryam
Publicado: (2012)

A Case of Cyclosporine-Induced Sebaceous Hyperplasia in a Renal Transplant Patient Successfully Treated with Isotretinoin
por: Jung, Hwa Young, et al.
Publicado: (2016)

Immunosuppression in Renal Transplantation and Dyslipidemia, Which Factors Should Be Considered?
por: De Giorgi, Alfredo, et al.
Publicado: (2013)

Acute myopathy induced by colchicine in a cyclosporine-treated renal transplant recipient--a case report and review of the literature.
por: Lee, B. I., et al.
Publicado: (1997)

Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A
por: Bertocchio, Jean-Philippe, et al.
Publicado: (2016)

The effects of diltiazem in renal transplantation patients treated with cyclosporine A()
por: Xue, Wujun, et al.
Publicado: (2010)

Early non-steady-state population pharmacokinetics of oral cyclosporine in renal transplant recipients
por: Baek, Hyunjeong, et al.
Publicado: (2014)

Tuberculosis in renal transplant recipient
por: Kalita, P., et al.
Publicado: (2010)

Pulmonary alveolar proteinosis due to mycophenolate and cyclosporine combination therapy in a renal transplant recipient
por: Hasan, Ashfaq, et al.
Publicado: (2014)

DIETARY MANAGEMENT FOR DYSLIPIDEMIA IN LIVER TRANSPLANT RECIPIENTS
por: PINTO, Andressa S., et al.
Publicado: (2016)

Renal cortical necrosis in a renal transplant recipient
por: Eswarappa, M., et al.
Publicado: (2013)

Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
por: Mansell, Holly, et al.
Publicado: (2022)

Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients
por: Handisurya, Ammon, et al.
Publicado: (2016)

Protean Faces of Infective Endocarditis in Renal Transplant Recipients
por: Ardalan, Mohammadreza
Publicado: (2014)

Costs of Long-Term Post-Transplantation Care in Kidney Transplant Recipients
por: Łabuś, Anna, et al.
Publicado: (2019)

The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
por: Lunde, Ingrid, et al.
Publicado: (2014)

Applying machine learning to the pharmacokinetic modeling of cyclosporine in adult renal transplant recipients: a multi-method comparison
por: Mao, Junjun, et al.
Publicado: (2022)

Adnexal torsion in an adolescent renal transplant recipient
por: Mishra, V. V., et al.
Publicado: (2016)

Electrolytes Disturbance and Cyclosporine Blood Levels among Kidney Transplant Recipients
por: Einollahi, B., et al.
Publicado: (2012)

The Efficacy and Safety of Ezetimibe and Low-Dose Simvastatin as a Primary Treatment for Dyslipidemia in Renal Transplant Recipients
por: Yoon, Hye Eun, et al.
Publicado: (2009)

Isolated Epidermolytic Acanthoma in a Renal Transplant Recipient
por: Yang, Ji-Hye, et al.
Publicado: (2011)

Strongyloid Hyperinfection Syndrome in a Renal Transplant Recipient
por: Sriperumbuduri, S., et al.
Publicado: (2017)

Lichen striatus successfully treated with oral cyclosporine
por: Romita, Paolo, et al.
Publicado: (2017)

The therapeutic effect of switching from tacrolimus to low-dose cyclosporine A in renal transplant recipients with BK virus nephropathy
por: Chen, Xu-Tao, et al.
Publicado: (2019)

Urinary Tract Abscess in Nephrectomized Renal Transplant Recipient
por: Afshar, Reza, et al.
Publicado: (2009)

Comparison between swallowing and chewing of garlic on levels of serum lipids, cyclosporine, creatinine and lipid peroxidation in Renal Transplant Recipients
por: Jabbari, Abbas, et al.
Publicado: (2005)

Could Salivary Cyclosporine Dosage Replace the Whole Blood Cyclosporine Measurements in Renal Transplant Patients?
por: Aboujaoude, Samia, et al.
Publicado: (2017)

Nocardiosis in a renal transplant recipient following rituximab preconditioning
por: Flohr, Tanya R, et al.
Publicado: (2009)

Disseminated Tuberculosis Involving Allograft in a Renal Transplant Recipient
por: Sutariya, Harsh C., et al.
Publicado: (2016)

Recurrent neutropenia induced by rifabutin in a renal transplant recipient
por: Chang, Ji Yeun, et al.
Publicado: (2014)

The Authors Reply: Renal Cell Carcinoma in Kidney Transplant Recipients and Dialysis Patients
por: Lee, Hyung Ho, et al.
Publicado: (2013)

Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection
por: Kemmner, Stephan, et al.
Publicado: (2020)

Antithymocyte globulin-induced refractory hypotension in renal transplantation recipient
por: Rafat, Shamim, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rbloacln1andhkok8ffe9s2te9